Podcast: KHN’s ‘What The Health?’ Doctors, Guns And Lame Ducks

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss how the Democrats’ takeover of the House and other results from the Nov. 6 elections might affect health care, and what Congress may have in store for the lame-duck session.

Billions In ‘Questionable Payments’ Went To California’s Medicaid Insurers And Providers

The money was paid on behalf of more than 400,000 people who may have been ineligible for the public program, a state audit found. One had been dead for four years before payments stopped.

Trump Adds A Global Pricing Plan To Wide Attack On Drug Prices, But Doubts Persist

Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.

Podcast: KHN’s ‘What The Health?’ Trump, GOP Fight Back On Health Care

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.

50-State Survey Finds Flat Medicaid Enrollment Tied to a Stronger Economy and New Eligibility Systems

For the first time in a decade, states are reporting no overall growth in Medicaid enrollment last year and expecting minimal growth this year amid a stronger economy, a new Kaiser Family Foundation survey finds. The 18th annual 50-state survey of Medi…

Podcast: KHN’s ‘What The Health?’ Republicans’ Preexisting Political Problem

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.

Podcast: KHN’s ‘What The Health?’ Falling Premiums And Rising Political Tensions

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.

The Feds’ Termination Of A Tiny Contract Inflames Bitter Fight Over Fetal Tissue

Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.

In The Battle To Control Drug Costs, Old Patent Laws Get New Life

Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications. 

Podcast: KHN’s ‘What The Health?’ Some Things Old, Some Things New

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner discuss final action on bills in Congress to address the opioid epidemic and fund federal health agencies. They also look at new efforts by the Food and Drug Administration to crack down on teen nicotine use.

Older posts «

Explore the Archive